A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
Identifieur interne : 005473 ( Main/Exploration ); précédent : 005472; suivant : 005474A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
Auteurs : Anne S. Reiner [États-Unis] ; Lindsay M. Jacks [États-Unis] ; Kimberly J. Van Zee [États-Unis] ; Katherine S. Panageas [États-Unis]Source :
- Breast cancer research and treatment [ 0167-6806 ] ; 2011.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Assurance maladie, Santé publique, Homme, Adulte.
English descriptors
- KwdEn :
Abstract
Each year there are an estimated 200,000 new breast cancer cases diagnosed in the United States; of these, 1% of cases are in men. Lymphedema can be a devastating complication from breast cancer and its treatment. Currently, almost all lymphedema-related research is based on women and extrapolated to men. We conducted the first population-based study of men with incident breast cancer of any stage, diagnosed from 1998 to 2005, who were 65 years and older in the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. We utilized claims related to lymphedema and lymphedema treatment in our cohort. We defined lymphedema-specific' claims to contain the word 'lymphedema' in the Medicare claim description; similarly, 'lymphedema-related' claims were defined as treatments reimbursed for lymphedema but not necessarily containing the word 'lymphedema' in the Medicare claim description. We identified 628 men with incident breast cancer from 1998 to 2005 who were 65 years and older. The cumulative incidence, censored for deaths, of lymphedema-specific claims at 2, 3, 4, and 5 years was 8.0, 9.2, 10.5, and 10.5%, respectively. The median follow-up was 3.4 years and for those without any event was 4.7 years. The cumulative incidence, censored for deaths, of lymphedema-related claims at 2, 3, 4, and 5 years was 26.9, 32.2, 35.4, and 39.8%. Rates for men were similar to analogous rates for women. Lymphedema is a common complication affecting men with breast cancer as well as women and appropriate treatment and rehabilitation strategies need to be implemented for both genders.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000149
- to stream PascalFrancis, to step Curation: 000809
- to stream PascalFrancis, to step Checkpoint: 000198
- to stream Main, to step Merge: 005520
- to stream Main, to step Curation: 005473
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men</title><author><name sortKey="Reiner, Anne S" sort="Reiner, Anne S" uniqKey="Reiner A" first="Anne S." last="Reiner">Anne S. Reiner</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street</s1><s2>New York, NY 10065</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Jacks, Lindsay M" sort="Jacks, Lindsay M" uniqKey="Jacks L" first="Lindsay M." last="Jacks">Lindsay M. Jacks</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Cancer Care Ontario, 505 University Avenue, 17th Floor</s1><s2>Toronto, ON M5G 1X3</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Toronto, ON M5G 1X3</wicri:noRegion></affiliation></author><author><name sortKey="Van Zee, Kimberly J" sort="Van Zee, Kimberly J" uniqKey="Van Zee K" first="Kimberly J." last="Van Zee">Kimberly J. Van Zee</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Surgery, Memorial Sloan-Kettering Cancer Center, Evelyn H. Lauder Breast Center, 300 E 66th Street, 8th Floor</s1><s2>New York, NY 10065</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Panageas, Katherine S" sort="Panageas, Katherine S" uniqKey="Panageas K" first="Katherine S." last="Panageas">Katherine S. Panageas</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street</s1><s2>New York, NY 10065</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">11-0457892</idno><date when="2011">2011</date><idno type="stanalyst">PASCAL 11-0457892 INIST</idno><idno type="RBID">Pascal:11-0457892</idno><idno type="wicri:Area/PascalFrancis/Corpus">000149</idno><idno type="wicri:Area/PascalFrancis/Curation">000809</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000198</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000198</idno><idno type="wicri:doubleKey">0167-6806:2011:Reiner A:a:seer:medicare</idno><idno type="wicri:Area/Main/Merge">005520</idno><idno type="wicri:Area/Main/Curation">005473</idno><idno type="wicri:Area/Main/Exploration">005473</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men</title><author><name sortKey="Reiner, Anne S" sort="Reiner, Anne S" uniqKey="Reiner A" first="Anne S." last="Reiner">Anne S. Reiner</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street</s1><s2>New York, NY 10065</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Jacks, Lindsay M" sort="Jacks, Lindsay M" uniqKey="Jacks L" first="Lindsay M." last="Jacks">Lindsay M. Jacks</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Cancer Care Ontario, 505 University Avenue, 17th Floor</s1><s2>Toronto, ON M5G 1X3</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Toronto, ON M5G 1X3</wicri:noRegion></affiliation></author><author><name sortKey="Van Zee, Kimberly J" sort="Van Zee, Kimberly J" uniqKey="Van Zee K" first="Kimberly J." last="Van Zee">Kimberly J. Van Zee</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Surgery, Memorial Sloan-Kettering Cancer Center, Evelyn H. Lauder Breast Center, 300 E 66th Street, 8th Floor</s1><s2>New York, NY 10065</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Panageas, Katherine S" sort="Panageas, Katherine S" uniqKey="Panageas K" first="Katherine S." last="Panageas">Katherine S. Panageas</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street</s1><s2>New York, NY 10065</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Breast cancer research and treatment</title><title level="j" type="abbreviated">Breast cancer res. treat.</title><idno type="ISSN">0167-6806</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Breast cancer research and treatment</title><title level="j" type="abbreviated">Breast cancer res. treat.</title><idno type="ISSN">0167-6806</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Breast cancer</term><term>Epidemiology</term><term>Health insurance</term><term>Human</term><term>Incidence</term><term>Lymphedema</term><term>Male</term><term>Public health</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Assurance maladie</term><term>Santé publique</term><term>Lymphoedème</term><term>Incidence</term><term>Epidémiologie</term><term>Cancer du sein</term><term>Homme</term><term>Adulte</term><term>Mâle</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Assurance maladie</term><term>Santé publique</term><term>Homme</term><term>Adulte</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Each year there are an estimated 200,000 new breast cancer cases diagnosed in the United States; of these, 1% of cases are in men. Lymphedema can be a devastating complication from breast cancer and its treatment. Currently, almost all lymphedema-related research is based on women and extrapolated to men. We conducted the first population-based study of men with incident breast cancer of any stage, diagnosed from 1998 to 2005, who were 65 years and older in the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. We utilized claims related to lymphedema and lymphedema treatment in our cohort. We defined lymphedema-specific' claims to contain the word 'lymphedema' in the Medicare claim description; similarly, 'lymphedema-related' claims were defined as treatments reimbursed for lymphedema but not necessarily containing the word 'lymphedema' in the Medicare claim description. We identified 628 men with incident breast cancer from 1998 to 2005 who were 65 years and older. The cumulative incidence, censored for deaths, of lymphedema-specific claims at 2, 3, 4, and 5 years was 8.0, 9.2, 10.5, and 10.5%, respectively. The median follow-up was 3.4 years and for those without any event was 4.7 years. The cumulative incidence, censored for deaths, of lymphedema-related claims at 2, 3, 4, and 5 years was 26.9, 32.2, 35.4, and 39.8%. Rates for men were similar to analogous rates for women. Lymphedema is a common complication affecting men with breast cancer as well as women and appropriate treatment and rehabilitation strategies need to be implemented for both genders.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Reiner, Anne S" sort="Reiner, Anne S" uniqKey="Reiner A" first="Anne S." last="Reiner">Anne S. Reiner</name></region><name sortKey="Jacks, Lindsay M" sort="Jacks, Lindsay M" uniqKey="Jacks L" first="Lindsay M." last="Jacks">Lindsay M. Jacks</name><name sortKey="Panageas, Katherine S" sort="Panageas, Katherine S" uniqKey="Panageas K" first="Katherine S." last="Panageas">Katherine S. Panageas</name><name sortKey="Van Zee, Kimberly J" sort="Van Zee, Kimberly J" uniqKey="Van Zee K" first="Kimberly J." last="Van Zee">Kimberly J. Van Zee</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005473 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005473 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:11-0457892
|texte= A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
}}
| This area was generated with Dilib version V0.6.31. |  |